Arbiter Partners Capital Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Arbiter Partners Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $573,578 - $1.01 Million	-193,124 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.67 - $4.97 $1.75 Million - $3.26 Million	-654,945 Reduced 77.23%	193,124 $608,000
Q4 2019 Feb 14, 2020	SELL	$2.93 - $4.5 $756,974 - $1.16 Million	-258,353 Reduced 23.35%	848,069 $3.42 Million
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $29,555 - $39,921	-5,514 Reduced 0.5%	1,106,422 $5.93 Million
Q4 2018 Feb 14, 2019	BUY	$4.8 - $11.6 $574,992 - $1.39 Million	119,790 Added 12.07%	1,111,936 $5.7 Million
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $1.95 Million - $2.36 Million	215,837 Added 27.8%	992,146 $9.62 Million
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $6.97 Million - $9.49 Million	682,959 Added 731.61%	776,309 $7.92 Million
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $1.18 Million - $1.76 Million	93,350 New	93,350 $1.21 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Arbiter Partners Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Arbiter Partners Capital Management LLC with notifications on news.